Pharmacological profiles of opioid ligands at Kappa opioid receptors

BMC Pharmacology

Volumn 6, Issue , 2006, Pages

  Gharagozlou, Parham ^a   Hashemi, Ezzat ^a   DeLorey, Timothy M ^a   Clark, J David ^b   Lameh, Jelveh ^a,c  

^a MOLECULAR RESEARCH INSTITUTE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c ACADIA PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; BUTORPHANOL; COMPLEMENTARY DNA; CYCLAZOCINE; CYCLIC AMP; DELTA OPIATE RECEPTOR; DEZOCINE; DYNORPHIN; ETORPHINE; FENTANYL; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; HYDROMORPHONE; KAPPA OPIATE RECEPTOR; LOFENTANIL; METAZOCINE; MORPHINE; MORPHINE SULFATE; N ALLYLNORMETAZOCINE; NALBUPHINE; NALORPHINE; NALTREXONE; OPIATE AGONIST; OPIATE DERIVATIVE; QUADAZOCINE; LIGAND; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; ENZYME INHIBITION; GENE ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CELL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; ANIMAL; CELL LINE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; MOUSE; PHYSIOLOGY; PROTEIN BINDING;

ANALGESICS, OPIOID; ANIMALS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIGANDS; MICE; NARCOTIC ANTAGONISTS; PROTEIN BINDING; RECEPTORS, OPIOID, KAPPA;

EID: 33645023823     PISSN: 14712210     EISSN: 14712210     Source Type: Journal    
DOI: 10.1186/1471-2210-6-3     Document Type: Article

References (24)

1. Neilan CL: Pharmacological characterization of the demorphine analog[Dmt(1)]DALDA, a highly potent and selective mu-opioid peptide. Eur J Pharmacol 2001, 419:15-23.
2. Porreca F, Burks TF: Handb. Exp. Pharmacol. 1993, 104:21-51.
3. Jaffe JM, Martin WR: Opioid analgesics and antagonists. In The Pharmacologic Basis of Therapeutics 8th edition. Edited by: Gilman A, Rall J, Nies M and Taylor P. New York, Pergamon Press; 1990:485-573.
4. Bilsky EJ, Bernstein RN, Wang Z, Sadee W, Porreca F: Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice. J Pharmacol Exp Ther 1996, 277:484-490.
5. Dhawan BN, Cesselin F, Raghubir R, Reisine T, Bradley PB, Portoghese PS, Hamon M: International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol Rev 1996, 48:567-592.
6. Parsons CG, West DC, Headley PM: Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration. Br J Pharmacol 1989, 98:533-543.
7. Metcalf G, Rees JM, Ward SJ: In vivo antagonism of analgesia and respiratory depression induced by proposed mu and kappa opiate agonists [proceedings]. Br J Pharmacol 1979, 66:473P-474P.
8. Gharagozlou P, Demirci H, Clark D, Lameh J: Activation profiles of opioid ligands in HEK cells expressing delta opioid receptors. BMC Neuroscience 2002, 3:19.
9. Gharagozlou P, Demirci H, Clark DJ, Lameh J: Activity of opioid ligands in cells expressing cloned mu opioid receptors. BMC Pharmacology 2003, 3:1.
10. Filizola M, Villar HO, Loew GH: Molecular determinants of non-specific recognition of delta, mu, and kappa opioid receptors. Bioorg Med Chem 2001, 9:69-76.
11. Reisine T, Pasternak G: Opioid Analgesics and Antagonists. In Goodman and Gilman's The Pharmacological Basis of Therapeutics 9th edition. Edited by: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW and Gilman AG. New York, McGraw-Hill Companies; 1996:521-549.
12. Chen JJ, Dymshitz J, Vasko MR: Regulation of opioid receptors in rat sensory neurons in culture. Mol Pharmacol 1997, 51:666-673.
13. Hjorth SA, Thirstrup K, Schwarts TW: Radioligand-dependent discrepancy in agonist affinities enhanced by mutations in the κ-opioid receptor. Mol Pharmacol 1996, 50:977-984.
14. Lameh J, Eiger S, Sadee W: Interaction among μ-opioid receptors and α2-adrenoceptors on SH-SY5Y human neuroblastoma cells. Eur J Pharmacol 1992, 227:19-24.
15. Yu VC, Eiger S, Duan DS, Lameh J, Sadee W: Regulation of cyclic AMP by the μ-opioid receptor in human neuroblastoma SH-SY5Y cells. Journal of Neurochemistry 1990, 55:1390-1396.
16. Segredo V, Burford NT, Lameh J, Sadee W: A constitutively internalizing and recycling mutant of the μ-opioid receptor. J Neurochem 1997, 68:2395-2404.
17. Arden JR, Segredo V, Wang Z, Lameh J, Sadee W: Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged μ-opioid receptor expressed in HEK 293 cells. J Neurochem 1995, 65:1636-1645.
18. Keith DE, Murray SR, Zaki PA, Chu PC, Lissin DV, Kang L, Evans CJ, von Zastrow M: Morphine activates opioid receptors without causing their rapid internalizaion. J Biol Chem 1996, 271(32):19021-19024.
19. Kieffer BL, Befort K, Gaveriaux-Guff C, Hirth CG: The delta opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci U S A 1992, 89:12048-12052.
20. Yoshimura M, Wu PH, Hoffman PL, Tabakoff B: Overexpression of type 7 adenylyl cyclase in the mouse brain enhances acute and chronic actions of morphine. Mol Pharmacol 2000, 58:1011-1016.
21. Suh HW, Sim YB, Choi YS, Song DK, Kim YH: Multiplicative interaction between intrathecally and intracerebroventricularly administered morphine for antinociception in the mouse: effects of spinally and supraspinally injected 3-isobutyl-1-methylxanthine, cholera toxin, and pertussis toxin. Gen Pharmacol 1995, 26:1597-1602.
22. Mantegazza P, Tammiso R, Zambotti F, Zecca L, Zonta N: Purine involvement in morphine antinociception. Br J Pharmacol 1984, 83:883-888.
23. Lameh J, Wang P, Meredith D, Shafer SL, Loew GH: Characterization of Benzodiazepine Receptors in the Cerebellum. Prog Neuro-Psychopharmacol & Biol Psychiat 2000, 24:979-991.
24. Hesley J, Daijo J, Ferguson AT: Stable, sensitive, fluorescence-based method for detecting cAMP. Biotechniques 2002, 33:691-694.